Literature DB >> 11909002

Bacteriophages: potential treatment for bacterial infections.

Donna H Duckworth1, Paul A Gulig.   

Abstract

Bacteriophages (phages) are viruses of bacteria that can kill and lyse the bacteria they infect. After their discovery early in the 20th century, phages were widely used to treat various bacterial diseases in people and animals. After this enthusiastic beginning to phage therapy, problems with inappropriate use and uncontrolled studies and ultimately the development of antibacterials caused a cessation of phage therapy research in the West. However, a few institutions in Eastern Europe continued to study and use phages as therapeutic agents for human infections. The alarming rise in antibacterial resistance among bacteria has led to a review of the Eastern European studies and to the initiation of controlled experiments in animal models. These recent studies have confirmed that phages can be highly effective in treating many different types of bacterial infections. The lethality and specificity of phages for particular bacteria, the ability of phages to replicate within infected animal hosts, and the safety of phages make them efficacious antibacterial agents. Although there are still several hurdles to be overcome, it appears likely that phage therapy will regain a role in both medical and veterinary treatment of infectious diseases, especially in the scenario of emerging antibacterial resistance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11909002     DOI: 10.2165/00063030-200216010-00006

Source DB:  PubMed          Journal:  BioDrugs        ISSN: 1173-8804            Impact factor:   5.807


  29 in total

1.  Isolation and characterization of a novel bacteriophage φ4D lytic against Enterococcus faecalis strains.

Authors:  Sylwia Parasion; Magdalena Kwiatek; Lidia Mizak; Romuald Gryko; Michał Bartoszcze; Janusz Kocik
Journal:  Curr Microbiol       Date:  2012-06-06       Impact factor: 2.188

2.  Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice.

Authors:  Ryohei Watanabe; Tetsuya Matsumoto; Go Sano; Yoshikazu Ishii; Kazuhiro Tateda; Yoshinobu Sumiyama; Jumpei Uchiyama; Shingo Sakurai; Shigenobu Matsuzaki; Shosuke Imai; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

3.  Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals.

Authors:  S O'Flaherty; R P Ross; W Meaney; G F Fitzgerald; M F Elbreki; A Coffey
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

4.  Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection.

Authors:  Lisa A Carmody; Jason J Gill; Elizabeth J Summer; Uma S Sajjan; Carlos F Gonzalez; Ryland F Young; John J LiPuma
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

Review 5.  Bacteriophages and its applications: an overview.

Authors:  Sonika Sharma; Soumya Chatterjee; Sibnarayan Datta; Rishika Prasad; Dharmendra Dubey; Rajesh Kumar Prasad; Mohan G Vairale
Journal:  Folia Microbiol (Praha)       Date:  2016-10-08       Impact factor: 2.099

6.  Occurrence of Vibrio parahaemolyticus and its specific phages from shrimp ponds in east coast of India.

Authors:  K M Alagappan; B Deivasigamani; S T Somasundaram; S Kumaran
Journal:  Curr Microbiol       Date:  2010-02-07       Impact factor: 2.188

7.  Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice.

Authors:  Karen E Cerveny; Angelo DePaola; Donna H Duckworth; Paul A Gulig
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 8.  Advanced biotechnology using methyltransferase and its applications in bacteria: a mini review.

Authors:  Jun Ren; Hyang-Mi Lee; JunHao Shen; Dokyun Na
Journal:  Biotechnol Lett       Date:  2021-11-25       Impact factor: 2.461

Review 9.  Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants.

Authors:  Adelaide Almeida; Angela Cunha; Newton C M Gomes; Eliana Alves; Liliana Costa; Maria A F Faustino
Journal:  Mar Drugs       Date:  2009-07-30       Impact factor: 5.118

Review 10.  Novel therapeutic interventions towards improved management of septic arthritis.

Authors:  Jian Wang; Liucai Wang
Journal:  BMC Musculoskelet Disord       Date:  2021-06-09       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.